Literature DB >> 8595147

The reversal of multidrug resistance.

G A Fisher1, B L Lum, B I Sikic.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8595147     DOI： 10.1007/978-1-4615-2007-8_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  4 in total

1.  Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.

Authors:  Xiao-Fei Zhou; Qingxiang Shao; Robert A Coburn; Marilyn E Morris
Journal:  Pharm Res       Date:  2005-09-20       Impact factor: 4.200

Review 2.  Diagnostics of multidrug resistance in cancer.

Authors:  G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Authors:  I C van der Sandt; P J Gaillard; H H Voorwinden; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

4.  Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).

Authors:  Milica Pesić; Tijana Andjelković; Jasna Banković; Ivanka D Marković; Ljubisa Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2008-05-21       Impact factor: 3.850
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.